[HTML][HTML] A rapid, whole genome sequencing assay for detection and characterization of novel coronavirus (SARS-CoV-2) clinical specimens using nanopore …
MT Arévalo, MA Karavis, SE Katoski, JV Harris… - Frontiers in …, 2022 - frontiersin.org
A new human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
emerged at the end of 2019 in Wuhan, China that caused a range of disease severities; …
emerged at the end of 2019 in Wuhan, China that caused a range of disease severities; …
A Rapid, Whole Genome Sequencing Assay for Detection and Characterization of Novel Coronavirus (SARS-CoV-2) Clinical Specimens Using Nanopore Sequencing
MT Arévalo, MA Karavis, SE Katoski… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
A new human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
emerged at the end of 2019 in Wuhan, China that caused a range of disease severities; …
emerged at the end of 2019 in Wuhan, China that caused a range of disease severities; …
A Rapid, Whole Genome Sequencing Assay for Detection and Characterization of Novel Coronavirus (SARS-CoV-2) Clinical Specimens Using Nanopore Sequencing
MT Arévalo, MA Karavis, SE Katoski, JV Harris, JM Hill… - 2022 - agris.fao.org
A new human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
emerged at the end of 2019 in Wuhan, China that caused a range of disease severities; …
emerged at the end of 2019 in Wuhan, China that caused a range of disease severities; …
A rapid, whole genome sequencing assay for detection and characterization of novel coronavirus (SARS-CoV-2) clinical specimens using nanopore sequencing.
MT Arévalo, MA Karavis, SE Katoski, JV Harris, JM Hill… - 2022 - cabidigitallibrary.org
A new human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
emerged at the end of 2019 in Wuhan, China that caused a range of disease severities; …
emerged at the end of 2019 in Wuhan, China that caused a range of disease severities; …
[PDF][PDF] Maria T. Arévalo1, 2*, Mark A. Karavis2, Sarah E. Katoski2, Jacquelyn V. Harris2, Jessica M. Hill3, Samir V. Deshpande2, Pierce A. Roth3, Alvin T. Liem3 and R …
M Antwerpen, J Hang, M Rueca… - … for epidemiologica l …, 2023 - researchgate.net
Arévalo et al. Rapid COVID-19 Nanopore Sequencing Assay of previous RT-PCR confirmed
patient samples, showed that the modified protocol produces high quality data, with up to …
patient samples, showed that the modified protocol produces high quality data, with up to …
[PDF][PDF] Maria T. Arévalo1, 2*, Mark A. Karavis2, Sarah E. Katoski2, Jacquelyn V. Harris2, Jessica M. Hill3, Samir V. Deshpande2, Pierce A. Roth3, Alvin T. Liem3 and R …
M Antwerpen, J Hang, M Rueca, MT Arévalo… - scienceopen.com
Arévalo et al. Rapid COVID-19 Nanopore Sequencing Assay of previous RT-PCR confirmed
patient samples, showed that the modified protocol produces high quality data, with up to …
patient samples, showed that the modified protocol produces high quality data, with up to …
[HTML][HTML] A Rapid, Whole Genome Sequencing Assay for Detection and Characterization of Novel Coronavirus (SARS-CoV-2) Clinical Specimens Using Nanopore …
MT Arévalo, MA Karavis, SE Katoski… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
A new human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
emerged at the end of 2019 in Wuhan, China that caused a range of disease severities; …
emerged at the end of 2019 in Wuhan, China that caused a range of disease severities; …
A Rapid, Whole Genome Sequencing Assay for Detection and Characterization of Novel Coronavirus (SARS-CoV-2) Clinical Specimens Using Nanopore Sequencing …
MT Arévalo, MA Karavis, SE Katoski… - Frontiers in …, 2022 - europepmc.org
A new human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
emerged at the end of 2019 in Wuhan, China that caused a range of disease severities; …
emerged at the end of 2019 in Wuhan, China that caused a range of disease severities; …